2025 Tutorial on Neoplastic Hematopathology: Focus on New Classifications

Phoenix, AZ US

January 20, 2025 to January 24, 2025

Continuing in the tradition of 40+ years of tutorials, the 2025 course is designed to update physicians on the latest advances in neoplastic hematopathology. It will be conducted under the direction of Dr. Daniel A. Arber at the Renaissance Phoenix Downtown Hotel from January 20–24, 2025. The program will consist of lectures, case presentations, and discussions designed to provide pathologists, pathologists-in-training, and medical oncologists/ hematologists with an in-depth discussion of diagnostic problems that arise in neoplastic hematopathology.

Target Audience

This activity is designed for pathologists and other healthcare professionals dedicated to the diagnosis of hematological malignancies.

Learning Objectives

At the conclusion of this activity, participants will be able to:

Identify how to evaluate and respond to diagnostic problems that arise in neoplastic hematopathology;
State how to utilize recent advances in the classification of hematopoietic tumors;
Discuss how to interpret and apply immunologic and molecular genetic findings in the diagnosis of neoplastic hematologic disease;
Describe how to implement the most recent classification of hematologic neoplasms;
Recall new discoveries that might impact future classifications of hematologic neoplasms;
Understand the prognostic and therapeutic significance of new molecular genetic markers of these tumors.

Additional information

ACGME/ABMS Core Competencies:

Medical Knowledge

Practice-based Learning and Improvement

For more information, please contact:

CME Coordinator Contact Name:

Thelma Wright

CME Coordinator Contact Email:

twright@bsd.uchicago.edu

CME Coordinator Contact Phone:

773-834-2555

Attachment	Size
Neoplastic Hematopathology Conference Brochure_FINAL.pdf	837.76 KB
TNH Exhibitor Prospectus 2025.pdf	958.8 KB

Summary

Available credit:

33.75 ABPath Lifelong Learning
33.75 AMA PRA Category 1 Credit™
33.75 Participation

Event starts:

01/20/2025 - 8:00am

Event ends:

01/24/2025 - 12:00pm

Activity opens:

06/10/2024

Activity expires:

04/24/2025

Add to calendar:

2025 Tutorial on Neoplastic Hematopathology: Focus on New Classifications

January 20-24, 2025

AGENDA

Monday, January 20

8:00 AM	Introductory Remarks	Daniel Arber, MD
Morning Session Chairperson: Daniel Arber, MD
8:15 AM	Normal Lymph Nodes and Reactive Hyperplasias	Rebecca King, MD
9:30 AM	Introduction to the Classification of Lymphoma	James Cook, MD
10:15 AM	BREAK
10:30 AM	Monoclonal B Lymphocytosis, Chronic Lymphocytic Leukemia and Related B-Cell Leukemias	Kathy Foucar, MD
11:45 AM	Questions
12:00 PM	LUNCH
Afternoon Session Chairperson: Kathy Foucar, MD
1:30 PM	Chronic T/NK Cell Leukemias	Kathy Foucar, MD
2:00 PM	Lymphoplasmacytic Lymphoma and Nodal and Extranodal Marginal Zone Lymphoma	James Cook, MD, PhD
3:00 PM	Questions
3:15 PM	BREAK
3:30 PM	Mantle Cell Lymphoma, Follicular Lymphoma and Variants	Rebecca King, MD
4:30 PM	Questions
4:45 PM- 5:30 PM	Case Presentations	Rebecca King, MD, James Cook, MD, PhD & Kathy Foucar, MD

Tuesday, January 21

Morning Session Chairperson: Michael Borowitz, MD
8:00 AM	Peripheral T Cell Lymphoma and Anaplastic Large Cell Lymphoma	Elaine Jaffe, MD
9:30 AM	Questions
9:45 AM	BREAK
10:00 AM	Acute Lymphoblastic Leukemia/Lymphoma and Acute Leukemias of Ambiguous Lineage	Michael Borowitz, MD
11:30 AM	Questions
11:45 AM	Case Presentations	Michael Borowitz, MD & Elaine Jaffe, MD
12:15 PM	LUNCH
Afternoon Session Chairperson: Rebecca King, MD
1:45 PM	Diffuse, Aggressive B Cell Lymphomas	Rebecca King, MD
2:45 PM	Questions
3:00 PM	BREAK
3:15 PM	Lymphoma Diagnosis: A Clinician’s Perspective	Javier Munoz, MD, MBA
4:15 PM	Questions
4:30 PM- 5:00 PM	Case Presentations	Rebecca King, MD

Wednesday, January 22

Morning Session Chairperson: Jonathan Said, MD
8:00 AM	Splenic Tumors	Daniel Arber, MD
9:00 AM	Hodgkin Lymphoma	Amy Chadburn, MD
10:00 AM	Questions
10:15 AM	BREAK
10:30 AM	Immunodeficiency-and Viral-Associated Lymphoproliferations	Jonathan Said, MD
11:45 AM	Questions
12:00 PM	LUNCH
Afternoon Session Chairperson: Amy Chadburn, MD
1:30 PM	Histiocytic Disorders	Amy Chadburn, MD
2:45 PM	Questions
3:00 PM	BREAK
3:15 PM	Cutaneous Lymphomas	Jonathan Said, MD
4:15 PM	Questions
4:30 PM- 5:00 PM	Case Presentations	Daniel Arber, MD Jonathan Said, MD & Amy Chadburn, MD

Thursday, January 23

Morning Session Chairperson: Adam Bagg, MD
8:00 AM	Introduction to the Classification of Myeloid Neoplasms and Acute Leukemia	Daniel Arber, MD
8:45 AM	Chronic Myeloid Leukemia	Adam Bagg, MD
9:30 AM	Questions
9:45 AM	BREAK
10:00 AM	BCR: ABL1--negative Myeloproliferative Neoplasms	Attilio Orazi, MD
11:00 AM	Eosinophilic Disorders	Adam Bagg, MD
11:45 AM	Questions
12:00 PM	LUNCH
Afternoon Session Chairperson: Robert Lorsbach, MD
1:30 PM	Clonal Cytopenias and Myelodysplastic Syndrome	Robert Hasserjian, MD
2:45 PM	Pediatric and Germline Predisposition Syndromes	Robert Lorsbach, MD
3:30 PM	Questions
3:45 PM	BREAK
4:00 PM	Plasma Cell Neoplasms	Robert Lorsbach, MD, PhD
4:45 PM	Questions
5:00 PM- 5:45 PM	Case Presentations	Robert Hasserjian, MD & Robert Lorsbach, MD, PhD

Friday, January 24

Morning Session Chairperson: Daniel Arber, MD
8:00 AM	Myelodysplastic/Myeloproliferative Neoplasms	Attilio Orazi, MD
9:00 AM	Acute Myeloid Leukemias	Daniel Arber, MD
10:00 AM	Questions
10:15 AM	BREAK
10:30 AM	Mastocytosis	Attilio Orazi, MD
11:15 AM	Case Presentations	Daniel Arber, MD & Attilio Orazi, MD
11:45 AM	Questions
12:00 PM- 12:30 PM	Concluding Remarks

Program agenda and speaker selection subject to change.

Renaissance Phoenix Downtown Hotel - IN PERSON ONLY

100 N 1st St

Phoenix, AZ 85004

United States

BOOKING INFORMATION

Accommodations have been reserved for Tutorial participants at Renaissance Phoenix Downtown Hotel. Note that a one-night deposit is required. To make reservations:

Follow this link: https://book.passkey.com/go/UNIVOFCHICAGO2025ATTENDEES
Call: 1-800-MARRIOT

Advise the reservations desk that you will be attending The University of Chicago Tutorial on Neoplastic Hematopathology from January 20-24, 2025 to receive the University of Chicago group rate. A confirmation number will be immediately assigned. The special daily rate for this meeting is $279/night (single/double). We strongly encourage on-line reservation bookings, as the hotel will charge a $10.00 booking fee for all reservations made via phone.

Reservations made after December 27, 2024, will be accepted on a space-available basis and rooms will not be available at the discounted group rate. Please make your reservations early!

For questions, please contact Thelma Wright via e-mail.

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 773-834-2555 or via email at twright@bsd.uchicago.edu.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

COURSE DIRECTOR

Daniel A. Arber, MD
Donald West and Mary Elizabeth King Professor

Chair, Department of Pathology
University of Chicago

ASSOCIATE COURSE DIRECTOR

Attilio Orazi, MD
Professor and Chair, Department of Pathology
Texas Tech University

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, the University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Pathology Lifelong Learning (CME) Credit
This activity has been registered to offer credit in the American Board of Pathology’s Continuing Certification program. Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 33.75 CME credits. Participants will earn credits equivalent to the amount of AMA PRA Category 1 Credits™ claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABPath Lifelong Learning (CME) credit.

Other Participant Credit
Other Participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABPath. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.

EXHIBIT OPPORTUNITIES AVAILABLE!

This conference offers a tremendous opportunity to highlight your company products, services, and achievements in front of a wide array of key decision-makers. Increase your company profile by participating as an exhibitor at this exciting event!

Last year's conference drew over 150 participants, including pathologists and other healthcare professionals specializing in hematology. Also in attendance will be our course faculty, including 14 world-renowned experts from across the country.

Download the prospectus or contact Thelma Wright at twright@bsd.uchicago.edu or 773-834-2555. We hope to see you there!

REGISTRATION

After logging in/creating an account, select your profession type below and click "Register Now!" Simply follow the prompts to complete your registration. For additional assistance, click

here.

Registration will be Sunday, January 19, 2025, from 4:30 to 6:30 p.m. & Monday, January 20, 2025, from 7:00 to 7:50 a.m., in the Salon Level Foyer. The conference will run from 8:00 a.m. to 6:00 p.m. Monday through Thursday and 8:00 a.m. to 12:30 p.m. on Friday.

The registration fee includes daily continental breakfast, coffee breaks and a reception. A continental-style breakfast will be provided each morning at 7:00 a.m. and refreshments will be served during breaks in the Salon 1-2 and Salon 3-4.

Enter the discount code during the registration process to receive the early rate!

Profession Type	Before 12/20/2024	Discount Code	After 12/20/2024
Practicing Physician	$1650	TNHE25	$1750
Other Healthcare Professionals	$1650	TNHE25	$1750
Physicians in Training	$900	TNHE25	$1000
Industry	$1650	TNHE25	$1750

CANCELLATION POLICY: If you cancel your participation in this conference, your registration fee less a $150 administrative fee will be refunded when written notification is received by January 2, 2025. No refunds will be made after January 2, 2025.

CLAIMING CREDIT

At the end of the course, the credit-claiming process will unlock. Return to this page and click on "Complete Activity" to proceed.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABPath. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.

Please login or create an account to proceed.

Center for Continuing Medical Education

Bookmark/Search this post

2025 Tutorial on Neoplastic Hematopathology: Focus on New Classifications

2025 Tutorial on Neoplastic Hematopathology: Focus on New Classifications

Target Audience